Financial Management Professionals’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89K Buy
18
+2
+13% +$383 ﹤0.01% 718
2026
Q1
$2.93K Hold
16
﹤0.01% 678
2025
Q4
$2.82K Hold
16
﹤0.01% 680
2025
Q3
$2.24K Hold
16
﹤0.01% 695
2025
Q2
$2.01K Buy
+16
New +$1.99K ﹤0.01% 749
2024
Q4
Sell
-31
Closed -$6K 993
2024
Q3
$6K Buy
31
+20
+182% +$4.18K ﹤0.01% 603
2024
Q2
$3K Buy
11
+5
+83% +$1.09K ﹤0.01% 635
2024
Q1
$1K Buy
+6
New +$1.41K ﹤0.01% 810

Other funds holding BIIB

Financial Management Professionals's BIIB Position: Q2 2026 in Review

Financial Management Professionals increased its Biogen (BIIB) stake by 13% in Q2 2026, buying an estimated $383 and bringing the position to 18 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #718.

Financial Management Professionals first reported a position in BIIB in Q1 2024 and has held it in 8 quarters since. The position peaked at $6K in Q3 2024. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Financial Management Professionals held 18 shares of Biogen worth $3.89K as of Q2 2026.
  • Financial Management Professionals bought 2 Biogen shares in Q2 2026, an estimated $383.
  • Biogen made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #718 holding.
  • Financial Management Professionals first reported a position in Biogen in Q1 2024 and has held it in 8 quarters since.
  • Financial Management Professionals's Biogen position peaked at $6K in Q3 2024.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.